BEWERBEN

Senior Phage Scientist


Mehr Jobs von PhagoMed Biopharma GmbH
Siehe Firmendetails

Kontakt: Dr. Lorenzo Corsini
Email: corsini@phagomed.com


PhagoMed is looking for a HIGH-CALIBRE MICROBIOLOGY SCIENTIST TO JOIN OUR TEAM as Senior Phage Scientist in Vienna, Austria

Do you want to be part of pioneering a high-profile antibiotics alternative and lead the research into first-in-class phage applications in areas of high medical need – together with a highly talented team and a network of leading physicians

Then apply for our current vacancy as

HEAD OF PHAGE RESEARCH (m/f)

WHAT WE ARE LOOKING FOR 

  • PhD or equivalent in microbiology, postdoc-level experience with bacteriophages;
  • Excellent publication track record in microbiology and phage research;
  • Track record of leading a team of research technicians and students, including steering and motivating the team;
  • Highly structured thinking;
  • Interest in targeted pharmaceutical development;
  • Interest in working in a team of highly skilled and motivated professionals

ROLE DESCRIPTION

  • Establish research processes according to the latest microbiological technology developments (e.g. robotics and data);
  • Establish and validate potency model for phages against bacteria in biofilm and planktonic growth;
  • Assembly of bacterial panels for species of interest, including in silico analysis of geno- and serotypes, to ensure required genetical and geographical breadth;
  • Selective breeding of phages, initially S. aureus, E. coli, S. epidermidis, to enhance selected properties, e.g. lytic activity in biofilm and pharmacokinetics;
  • As required, search for new phages, to complement gaps in coverage by contract research partners;
  • Establish standardized experimental protocols that will enable reproducibility in later GLP studies (e.g. potency, phage production and purification, phage evolution);
  • Documentation of results according to the PhagoMed Quality Standards (in development, non-GLP but as close as possible), to ensure the quality of results and their documentation are acceptable to regulatory authorities, working towards a human clinical trial application;
  • Supervise technical assistants, including training on working with bacteria and phages, working in a BSL-2 environment, application of experimental and documentation standards;
  • Drafting of patent claims as appropriate, publication of selected results in scientific journals

WHAT WE OFFER 

  • Become part of developing a new asset class in anti-infectives
  • Lead other researchers and develop into a leadership role within PhagoMed
  • Take full responsibility for key elements of the PhagoMed development plan
  • Pioneer new methods and processes to industrialize key phage research techniques
  • Be part of a highly motivated and fun team that believes phage therapy can be part of the solution to the antibiotics crisis
  • Due to legal requirements, we are required to state that the minimum salary for this job is a monthly salary of EUR 3.000, - gross. The actual salary will of course depend on the qualifications and seniority of the candidate and we are happy to discuss overpayment as well as equity-based incentives

WHAT MOTIVATES US?

Phages have a natural ability to infect and lyse bacteria that is independent of antibiotics resistances. They also have highly desirable pharmaceutical properties: they are self-replicating and self-limiting, they have proven effectiveness against biofilms and have no known serious side effects. For many bacterial infections, natural, lytic phages are a promising alternative to antibiotics, but to this date no phage-based pharmaceuticals are on the market in either the US or the EU.

WHO AND WHAT IS PHAGOMED?

PhagoMed Biopharma GmbH is a pre-clinical Biotech company dedicated to developing phage-based pharmaceuticals for the developed markets. PhagoMed builds on the clinical experience of its two co-founders (Prof. Burkhard Wippermann & PD Dr. Andrej Trampuz), who have treated patients in Germany with phage therapy for the past twenty years (Last resort treatments as defined by Art. 37 of the Helsinki declaration). The company was incorporated in 2017 and PhagoMed has secured financing from private investors and the Austrian government to scale-up its research efforts into phage therapy for two indications: Periprosthetic Joint Infections (PJI) and Urinary Tract Infections (UTI). For both indications, PhagoMed has partnered with Opinion Leaders in the field, who can help to define how a phage-based product can fit into today’s treatment guidelines and provide a strong benefit to patients.

PhagoMed’s vision is to accelerate the re-introduction of phage therapy into Western medicine across a range of indications and thereby to bring the benefits of this overlooked treatment alternative to patients as fast as possible.

INTERESTED? PLEASE CONTACT US!

To submit your application, please click on the following link:

Submit your application

Please also feel free to reach out directly if you have specific questions:

Dr. Lorenzo Corsini,

Managing Director & COO, PhagoMed

corsini@phagomed.com

 

 


Bitte beziehen Sie sich bei Ihrer Bewerbung auf biotechjobs.at
BEWERBEN

ARBEITGEBER


MÖGLICHKEITEN ARBEITGEBER

PARTNER

KONTAKT

REGISTRIERUNG

JOBPLATTFORM


VISION

BILDUNG

FACEBOOK

BETREIBER


© EPIFRAME.COM

IMPRESSUM

WEITERE PLATTFORMEN


JOBCITY.AT

BIOTECHJOBS.AT

IT-KARRIERE.AT

BUSINESSJOBS.AT